Products Products
Mutual Funds
Stock Market
NPS Retirement Funds

Company Company
About us
Contact us
1000003708
Paytm
Mutual Funds Stock Market NPS Retirement Funds
About us Contact us

Panacea Biotec

495.20
-7.25 (-1.44%) tick BSE

Buy Sell

Last updated on 9 May 2025 03:53 PM

Returns
-9.10%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

3077.54

Earning Per Share

0.58

Dividend Yield

-%

P/E Ratio

209.14

P/B Ratio

9.72

Debt to Equity

0.32

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on February 2, 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines. The Company has collaborations and tie-ups with leading national and international research organizations and corporations. PBL has ultra modern, state-of-art production facilities at Himachal Pradesh, Punjab & Delhi for manufacturing vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SAMCC and WHO-cGMP standards and it has four research and development centers. The plant for vaccines production (Radicura Pharma) and pharmaceutical formulations plant (Panacea Drug P Ltd) at New Delhi were established during the year 1988 and 1989 respectively.

Similar Companies


Login